The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Schuling Douglas A since 2008.
The trader's CIK number is 1414837.
At the time of the last reporting, Schuling Douglas A was the Ex VP and CFO of Miragen Therapeutics, Inc.. (stock ticker symbol MGEN).
Also see all insider trading activities at Miragen Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | SGNL | 0 | $0 | 0 | $0 | 5,500 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | GXDX | 0 | $0 | 0 | $0 | 93,142 | $681,333 |
| 2010 | GXDX | 0 | $0 | 27,720 | $937,751 | 27,720 | $36,025 |
| 2009 | GXDX | 0 | $0 | 39,934 | $1,216,021 | 39,934 | $40,045 |
| 2008 | GXDX | 0 | $0 | 40,752 | $1,039,176 | 40,710 | $32,975 |
1. Miragen Therapeutics, Inc. (SGNL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-08-06 | SGNL | Option Ex | 4,125 | .00 | 0 |
| 2015-07-17 | SGNL | Option Ex | 1,375 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-02-26 | GXDX | Option Ex | 93,142 | 7.32 | 681,333 |
| 2010-11-17 | GXDX | Option Ex | 1,562 | 9.50 | 14,839 |
| 2010-11-17 | GXDX | Sale | 1,562 | 16.93 | 26,439 |
| 2010-04-13 | GXDX | Sale | 7,582 | 37.31 | 282,922 |
| 2010-04-13 | GXDX | Option Ex | 7,582 | .81 | 6,141 |
| 2010-03-11 | GXDX | Option Ex | 5,497 | .81 | 4,452 |
| 2010-03-11 | GXDX | Sale | 5,497 | 33.89 | 186,271 |
| 2010-02-11 | GXDX | Option Ex | 5,497 | .81 | 4,452 |
| 2010-02-11 | GXDX | Sale | 5,497 | 31.18 | 171,374 |
| 2010-01-14 | GXDX | Sale | 7,582 | 35.71 | 270,745 |
| 2010-01-14 | GXDX | Option Ex | 7,582 | .81 | 6,141 |
| 2009-10-13 | GXDX | Option Ex | 326 | .38 | 123 |
| 2009-10-13 | GXDX | Sale | 326 | 35.27 | 11,497 |
| 2009-09-14 | GXDX | Sale | 4,828 | 32.02 | 154,607 |
| 2009-09-14 | GXDX | Option Ex | 4,828 | .38 | 1,834 |
| 2009-08-13 | GXDX | Option Ex | 3,328 | .38 | 1,264 |
| 2009-08-13 | GXDX | Sale | 3,328 | 29.41 | 97,873 |
| 2009-07-14 | GXDX | Option Ex | 3,328 | .38 | 1,264 |
| 2009-07-14 | GXDX | Sale | 3,328 | 26.95 | 89,696 |
| 2009-06-11 | GXDX | Option Ex | 3,328 | .38 | 1,264 |
| 2009-06-11 | GXDX | Sale | 3,328 | 28.12 | 93,600 |
| 2009-05-13 | GXDX | Option Ex | 3,328 | .38 | 1,264 |
| 2009-05-13 | GXDX | Sale | 3,328 | 27.17 | 90,428 |
| 2009-04-14 | GXDX | Option Ex | 3,328 | .38 | 1,264 |
| 2009-04-14 | GXDX | Sale | 3,328 | 25.50 | 84,877 |
| 2009-03-13 | GXDX | Option Ex | 1,500 | .38 | 570 |
| 2009-03-12 | GXDX | Option Ex | 3,328 | .38 | 1,264 |
| 2009-03-13 | GXDX | Sale | 1,500 | 30.00 | 45,000 |
| 2009-03-12 | GXDX | Sale | 3,328 | 28.41 | 94,555 |
| 2009-02-12 | GXDX | Option Ex | 4,828 | .38 | 1,834 |
| 2009-02-13 | GXDX | Sale | 1,828 | 35.00 | 63,980 |
| 2009-02-12 | GXDX | Sale | 4,828 | 33.31 | 160,825 |
| 2009-02-13 | GXDX | Option Ex | 1,828 | .38 | 694 |
| 2009-01-15 | GXDX | Option Ex | 1,828 | .81 | 1,480 |
| 2009-01-14 | GXDX | Sale | 4,828 | 34.20 | 165,103 |
| 2009-01-15 | GXDX | Sale | 1,828 | 35.00 | 63,980 |
| 2009-01-14 | GXDX | Option Ex | 4,828 | 5.37 | 25,926 |
| 2008-03-05 | GXDX | Sale | 40,752 | 25.50 | 1,039,176 |
| 2008-02-28 | GXDX | Option Ex | 40,710 | .81 | 32,975 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schuling Douglas A (Ex VP and CFO of Miragen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.